Latest News about SLRN
Recent news which mentions SLRN
Nasdaq Down 1.5%; RPM Posts Upbeat Results
January 07, 2025
From Benzinga
Dow Surges Over 100 Points; US Trade Deficit Widens In November
January 07, 2025
From Benzinga
From Benzinga
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
January 07, 2025
From Benzinga
What's Going On With ACELYRIN Shares Friday?
January 03, 2025
From Benzinga
Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday
January 03, 2025
From Benzinga
Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 11, 2024
From Benzinga
Earnings Scheduled For November 13, 2024
November 13, 2024
From Benzinga
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
August 20, 2024
From Benzinga
Acelyrin Cuts Workforce, Deprioritizes Former Lead Drug Izokibep
August 14, 2024
From Benzinga
Ouster Reports Weak Sales, Joins Brinker International And Other Big Stocks Moving Lower In Wednesday Pre-Market Session
August 14, 2024
From Benzinga
SLRN Stock Earnings: Acelyrin Misses EPS for Q2 2024
August 13, 2024
Tickers
SLRN
From InvestorPlace
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 08, 2024
From Benzinga
Investors Cheer Acelyrin's Stock, Its Second Lead Candidate Shows Clinical Benefit In Thyroid Eye Disease Patients
March 20, 2024
From Benzinga
Acelyrin's Lead Drug Candidate Hits Primary Goal In Late-Stage Psoriatic Arthritis Study
March 11, 2024
From Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
From InvestorPlace
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 28, 2023
From Benzinga
Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?
November 28, 2023
From Benzinga
Earnings Scheduled For November 7, 2023
November 07, 2023
From Benzinga
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
September 30, 2023
From InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
From Benzinga
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 13, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
September 13, 2023
From Benzinga
Despite Trial Setback For Acelyrin's Lead Program, Analyst Shows Optimism
September 12, 2023
Tickers
SLRN
From Benzinga